← brief for 2026-09-04 · Slowing decline

SGLT2 inhibitor ameliorates hypertension by regulating the CYP4A/20-HETE pathway in the kidney.

Article D Peer reviewed Preclinical

Key takeaways

SGLT2 drugs lower blood pressure, and this study asked how they do it. The drug acted on a chemical pathway inside the kidney, called CYP4A and 20-HETE, that helps set blood pressure. This was done in animals and cells, not in people yet. It offers an explanation for a known effect rather than a new benefit.

Who did this work

Zhou Z · Hang W · Zhao R · Jiang J · Wu J · Wang DW

Source

Article · PubMed, the drug frontier · 2026 Sep 4
https://pubmed.ncbi.nlm.nih.gov/42695342/